Mayra Hurtado

Mayra is a visionary entrepreneur and holistic wellbeing advocate with over two decades of corporate experience spanning marketing, finance, and operations. Her professional path has seen her making significant impacts in various sectors, from a biopharma startup to leading roles at adidas Southeast Asia and Pacific, and steering the Global Sales and Marketing team for a women's health startup. Mayra is now CEO and Co-Founder of Hormony (Prelude Health), a pioneering Femtech startup, dedicated to empowering women by demystifying perimenopause and hormonal health through the world’s first revolutionary at-home salivary tests for cortisol and AI-driven solutions.

2 Articles Published | Follow:
FemTech, Adidas, and cracking the code to product success

In today’s crowded marketplace, with countless products competing for attention, some startups manage to break through and become indispensable. These are the startups that see swathes of investment and rapid scaling, but this isn’t always the case – particularly for female founders.

From Taboos to Tech: navigating cultural shifts in Southeast Asia’s femtech landscape

FemTech has seen an astronomical rise in recent years. Last year alone, Forbes and Dealroom reported that 2023 saw $1.14 billion raised across 120 ‘FemTech’ deals. Meanwhile, the FemTech Landscape Report estimates that by the end of 2027, the industry as a whole will be worth over $1 trillion. What does this tell us? That the opportunities for startups and investors alike is staggering.